Systematic Financial Management LP Raises Holdings in Encompass Health Corporation $EHC

Systematic Financial Management LP lifted its stake in Encompass Health Corporation (NYSE:EHC) by 1.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 446,405 shares of the company’s stock after purchasing an additional 5,653 shares during the quarter. Encompass Health comprises about 1.0% of Systematic Financial Management LP’s portfolio, making the stock its 23rd largest holding. Systematic Financial Management LP’s holdings in Encompass Health were worth $43,181,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of EHC. WPG Advisers LLC grew its position in Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after purchasing an additional 137 shares during the last quarter. Flagship Harbor Advisors LLC purchased a new position in shares of Encompass Health in the fourth quarter worth $37,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after buying an additional 362 shares during the last quarter. Assetmark Inc. lifted its stake in shares of Encompass Health by 89.6% during the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock worth $44,000 after buying an additional 215 shares during the period. Finally, Aster Capital Management DIFC Ltd acquired a new stake in shares of Encompass Health during the fourth quarter worth $55,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Weiss Ratings downgraded Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Leerink Partners set a $152.00 price target on Encompass Health in a research note on Friday, May 22nd. TD Cowen assumed coverage on Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective on the stock. Finally, Barclays reduced their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $143.86.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total transaction of $71,309.92. Following the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.80% of the stock is currently owned by insiders.

Encompass Health Stock Up 0.1%

Shares of EHC opened at $111.09 on Friday. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 12 month low of $92.77 and a 12 month high of $127.99. The stock’s 50 day moving average is $104.85 and its two-hundred day moving average is $103.74. The firm has a market cap of $11.02 billion, a P/E ratio of 18.55, a PEG ratio of 2.42 and a beta of 0.74.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same period in the prior year, the company posted $1.37 EPS. The business’s quarterly revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Analysts predict that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.21 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio (DPR) is currently 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.